2022
Addressing Racial, Ethnic, and Age Disparities in Cancer Clinical Trial Enrollment
Gaddy JJ, Gross CP. Addressing Racial, Ethnic, and Age Disparities in Cancer Clinical Trial Enrollment. JAMA Oncology 2022, 8: 1792-1793. PMID: 36301581, DOI: 10.1001/jamaoncol.2022.5006.Peer-Reviewed Original Research
2021
The Ethical Imperative of Equity in Oncology: Lessons Learned From 2020 and a Path Forward.
Marron J, Charlot M, Gaddy J, Rosenberg A. The Ethical Imperative of Equity in Oncology: Lessons Learned From 2020 and a Path Forward. American Society Of Clinical Oncology Educational Book 2021, 41: e13-e19. PMID: 34061560, DOI: 10.1200/edbk_100029.Peer-Reviewed Original ResearchConceptsU.S. health careOncology communityProfessional medical organizationsCancer careRacial/ethnic disparitiesOncology workforceHealth careStructural racismMedical organizationsOncologyClinical practiceEthical principlesEthical responsibilityPracticing oncologistsEthical imperativesCareCOVID-19 pandemicOptimize equityUnited StatesCOVID-19CommunityDisparitiesWork—andInequalityWorkforce
2016
Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter?
Moses K, Orom H, Brasel A, Gaddy J, Underwood W. Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter? Urology 2016, 99: 76-83. PMID: 27667157, PMCID: PMC5191943, DOI: 10.1016/j.urology.2016.07.045.Peer-Reviewed Original ResearchConceptsProstate cancerOdds of receiving treatmentReceipt of treatmentDefinitive treatmentHispanic menWhite menD'Amico risk classificationDisease severityContext of disease severityOdds of treatmentLogistic regression analysisApproach to treatmentIntermediate-riskDecreased oddsHigh riskAA menAsian menRisk categoriesRisk classificationCancerProstateTreatmentRegression analysisMenTreatment variation